Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - dosulepin hydrochloride - film coated tablet - 75 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - dosulepin hydrochloride - capsules hard - 25 milligram

New Zealand - English - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - dosulepin hydrochloride 25mg;   - capsule - 25 mg - active: dosulepin hydrochloride 25mg   excipient: gelatin glycerol magnesium stearate maize starch

New Zealand - English - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - dosulepin hydrochloride 75mg;   - tablet - 75 mg - active: dosulepin hydrochloride 75mg   excipient: calcium phosphate chalk glucose liquid interwhite markem ink magnesium stearate maize starch povidone sandarac sucrose urethane dimethacrylate luting resin white beeswax

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - dosulepin (dothiepin) hydrochloride, quantity: 75 mg - tablet - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; povidone; purified talc; sodium starch glycollate; titanium dioxide; xanthan gum; polyvinyl alcohol; brilliant scarlet 4r; lecithin

Ireland - English - HPRA (Health Products Regulatory Authority)

teofarma s.r.l. - dothiepine hydrochloride - capsule, hard - 25mg milligram(s) - non-selective monoamine reuptake inhibitors; dosulepin

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - dosulepin hydrochloride - film coated tablet - 75 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - oxybutynin hydrochloride - tablets - 2.5 milligram - oxybutynin

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - oxybutynin hydrochloride - tablets - 5 milligram - oxybutynin

Ireland - English - HPRA (Health Products Regulatory Authority)

syri limited, t/a thame laboratories - oxybutynin hydrochloride - oral solution - 2.5 mg/5ml - oxybutynin - anticholinergic as well as antispasmodic - urinary incontinence, urgency and frequency in the unstable bladder, whether due to neurogenic bladder disorders (detrusor hyperreflexia) in conditions such as multiple sclerosis and spina bifida, or to idiopathic detrusor instability (motor urge incontinence).